Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors

被引：0
|
作者：
Karin Oechsle
Carsten Bokemeyer
Friedemann Honecker
机构：
[1] University Medical Center Eppendorf,Departments of Oncology, Hematology, Bone Marrow Transplantation and Pneumology
来源：
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷 / 1期
关键词：
D O I：
10.1007/s00432-009-0697-y
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors
    G. Varuni Kondagunta
    Jennifer Bacik
    Lawrence Schwartz
    Joel Sheinfeld
    Dean Bajorin
    Jacqueline Vuky
    Stephanie Marion
    Madhu Mazumdar
    George J. Bosl
    Robert J. Motzer
    Investigational New Drugs, 2004, 22 : 177 - 179
  • [12] Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors
    Vuky, J
    McCaffrey, J
    Ginsberg, M
    Mariani, T
    Bajorin, DF
    Bosl, GJ
    Motzer, RJ
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (03) : 265 - 267
  • [13] Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
    Feldman, Darren R.
    Kondagunta, G. Varuni
    Ginsberg, Michelle S.
    Ishill, Nicole
    Patil, Sujata
    Cestaro, John
    Obbens, Eugenie
    Sheinfeld, Joel
    Bosl, George J.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 487 - 490
  • [14] Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
    Darren R. Feldman
    G. Varuni Kondagunta
    Michelle S. Ginsberg
    Nicole Ishill
    Sujata Patil
    John Cestaro
    Eugenie Obbens
    Joel Sheinfeld
    George J. Bosl
    Robert J. Motzer
    Investigational New Drugs, 2007, 25 : 487 - 490
  • [15] Phase II Trial of Pyrazoloacridine in Patients with Cisplatin-Refractory Germ Cell Tumors
    Jacqueline Vuky
    John McCaffrey
    Michelle Ginsberg
    Tania Mariani
    Dean F. Bajorin
    George J. Bosl
    Robert J. Motzer
    Investigational New Drugs, 2000, 18 : 265 - 267
  • [16] Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors
    Kondagunta, GV
    Bacik, J
    Schwartz, L
    Sheinfeld, J
    Bajorin, D
    Vuky, J
    Marion, S
    Mazumdar, M
    Bosl, GJ
    Motzer, RJ
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (02) : 177 - 179
  • [17] Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors:: a study of the German Testicular Cancer Study Group
    Bokemeyer, C.
    Oechsle, K.
    Honecker, F.
    Mayer, F.
    Hartmann, J. T.
    Waller, C. F.
    Boehlke, I.
    Kollmannsberger, C.
    ANNALS OF ONCOLOGY, 2008, 19 (03) : 448 - 453
  • [18] An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors
    Oechsle, Karin
    Honecker, Friedemann
    Kollmannsberger, Christian
    Rick, Oliver
    Gruenwald, Victor
    Mayer, Frank
    Hartmann, Joerg T.
    Bokemeyer, Carsten
    ANTI-CANCER DRUGS, 2007, 18 (03) : 273 - 276
  • [19] Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
    Oechsle, Karin
    Kollmannsberger, Christian
    Honecker, Friedemann
    Mayer, Frank
    Waller, Cornelius F.
    Hartmann, Joerg T.
    Boehlke, Ina
    Bokemeyer, Carsten
    EUROPEAN UROLOGY, 2011, 60 (04) : 850 - 855
  • [20] Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study
    Pectasides, D
    Pectasides, M
    Farmakis, D
    Aravantinos, G
    Nikolaou, M
    Koumpou, M
    Gaglia, A
    Kostopoulou, V
    Mylonakis, N
    Skarlos, D
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 493 - 497
12345